Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

NCCN zdieľa najnovšie odborné odporúčania pre rakovinu prostaty v španielčine a portugalčine
  • USA - English
  • India - English
  • Latin America - español
  • Brazil - Português
  • USA - Pусский
  • USA - Deutsch
  • USA - Polski
  • USA - čeština
  • USA - Français
  • USA - español

NCCN Logo (C)NCCN(R) 2018. All rights reserved.

News provided by

National Comprehensive Cancer Network

Sep 08, 2021, 03:37 ET

Share this article

Share toX

Share this article

Share toX

Počas mesiaca povedomia o rakovine prostaty Národná komplexná sieť pre rakovinu vyhlasuje aktuálne, preložené usmernenia uvádzajúce nedávny pokrok v starostlivosti o jeden z najbežnejších typov rakoviny, dostupné na NCCN.org/global.

PLYMOUTH MEETING, Pa., Sept. 8, 2021 /PRNewswire/ -- National Comprehensive Cancer Network® (NCCN®) - nezisková aliancia popredných rakovinových centier v USA - oznamuje nedávno aktualizované verzie dôkazov a odborných zásad založených na konsenze na liečbu rakoviny prostaty, preložené do španielčiny a portugalčiny. Pokyny pre klinickú prax NCCN v onkológii (NCCN Guidelines®) obsahujú často aktualizované odporúčania pre liečbu rakoviny od multidisciplinárnych panelov odborníkov z členských inštitúcií NCCN. Nezávislé štúdie opakovane zistili, že dodržiavanie týchto odporúčaní koreluje s lepšími výsledkami a dlhším prežitím.

 

„Každý, kto má rakovinu prostaty, by mal mať prístup k starostlivosti, ktorá je založená na aktuálnych a spoľahlivých dôkazoch," povedal Robert W. Carlson, MD, generálny riaditeľ NCCN. „Tieto aktualizované preklady, spolu so všetkými našimi ďalšími preloženými a upravenými zdrojmi, nám pomáhajú globálne definovať a presadzovať vysokokvalitnú a hodnotnú starostlivosť o rakovinu zameranú na pacienta, aby pacienti na celom svete mohli žiť lepší život."

Rakovina prostaty je druhým najčastejšie sa vyskytujúcim nádorovým ochorením u mužov, pričom každoročne postihne viac ako milión ľudí na celom svete.1 V roku 2020 si ľudia mimo USA stiahli pokyny NCCN® pre rakovinu prostaty viac ako 200 000-krát. Približne 47 percent registrovaných používateľov NCCN.org sa nachádza mimo USA, pričom medzi desať najlepších krajín patrí Brazília, Španielsko a Mexiko.

„Pokyny NCCN sú neuveriteľne užitočnými zdrojmi v práci, ktorú robíme, aby sme zaistili, že starostlivosť o rakovinu v celej Latinskej Amerike bude spĺňať najvyššie štandardy," povedali Diogo Bastos, MD a Andrey Soares, MD, predseda a vedecký riaditeľ Genitourinárnej skupiny latinskoamerickej onkologickej skupiny ( LACOG ). Organizácia v minulosti spolupracovala s NCCN na vývoji latinskoamerických vydaní smerníc NCCN pre rakovinu prsníka, rakovinu hrubého čreva, nemalobunkový karcinóm pľúc, rakovinu prostaty, mnohopočetný myelóm a rakovinu konečníka a začiatkom roka spoluorganizovala webinár na tému „ Riadenie rakoviny prostaty v Latinskej Amerike ". „Ceníme si všetko úsilie NCCN o zabezpečenie toho, aby tieto zlaté štandardy boli prístupné osobám, ktoré nehovoria anglicky a sú použiteľné pre rôzne okolnosti."

NCCN taktiež vydáva Pokyny NCCN pre pacientov®, obsahujúce rovnaké informácie o liečbe v nelekárskom slovníku, a tieto sú určené pre pacientov a opatrovateľov. Podľa nedávnej medzinárodnej štúdie bolo zistené, že Pokyny NCCN pre pacientov: Rakovina prostaty patria medzi najdôveryhodnejšie zdroje online informácií. Tieto pokyny pre pacientov sú rozdelené do dvoch kníh, ktoré sa zaoberajú včasným a pokročilým karcinómom prostaty; obe boli preložené aj do španielčiny a portugalčiny .

NCCN spolupracuje s organizáciami na celom svete na zdrojoch založených na smerniciach NCCN, ktoré zohľadňujú miestnu prístupnosť, zohľadnenie metabolických rozdielov v populáciách a regionálne regulačné odchýlky. Môžu byť stiahnuté bezplatne na nekomerčné použitie na NCCN.org/global alebo prostredníctvom virtuálnej knižnice NCCN Guidelines App . Získajte viac informácií a zapojte sa do konverzácie s hashtagom #NCCNGlobal .

O organizácii National Comprehensive Cancer Network
National Comprehensive Cancer Network® ( NCCN ®) je nezisková aliancia popredných rakovinových centier zameraná na starostlivosť o pacienta, výskum a vzdelávanie. NCCN sa zameriava na zlepšovanie a uľahčovanie kvalitnej, efektívnej a prístupnej starostlivosti o rakovinu, aby pacienti mohli žiť lepší život. Pokyny NCCN pre klinickú prax v onkológii ( NCCN Guidelines ®) poskytujú transparentné, na dôkazoch založené, odborné konsenzuálne odporúčania pre liečbu rakoviny, prevenciu a podporné služby; sú uznávaným štandardom pre klinický smer a politiku v manažmente rakoviny a najdôkladnejšími a často aktualizovanými pokynmi klinickej praxe dostupnými v akejkoľvek oblasti medicíny. Pokyny NCCN pre pacientov® poskytujú odborné informácie o liečbe rakoviny s cieľom informovať a posilniť postavenie pacientov a opatrovateľov prostredníctvom podpory Nadácie NCCN Foundation®. NCCN tiež rozvíja ďalšie vzdelávanie, globálne iniciatívy, politiku a spoluprácu v oblasti výskumu a publikovanie v onkológii. Navštívte NNCCN.org, kde nájdete ďalšie informácie, a sledujte NCCN na Facebooku @NCCNorg, Instagrame @NCCNorg a Twitteri @NCCN.

1  Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Globálna štatistika rakoviny 2018: GLOBOCAN odhady incidencie a úmrtnosti na celom svete na 36 rakovín v 185 krajinách.CA Cancer J Clin, in press. Online databáza GLOBOCAN 2018 je prístupná na http://gco.iarc.fr/, ako súčasť Globálneho observatória rakoviny IARC.

Kontakt pre médiá:
Rachel Darwin
267-622-6624
[email protected]  

Logo - https://mma.prnewswire.com/media/441768/NCCN_Logo.jpg

 

Related Links

www.nccn.org

21%

more press release views with 
Request a Demo

Modal title

Also from this source

New JNCCN Study Confirms it's 'Never Too Late' to See Survival Benefits from Quitting Smoking--Even With Late-Stage Cancer

New JNCCN Study Confirms it's 'Never Too Late' to See Survival Benefits from Quitting Smoking--Even With Late-Stage Cancer

New research published online in JNCCN—Journal of the National Comprehensive Cancer Network finds that people with cancer who quit smoking had a much ...

NCCN Guidelines Navigator for Breast Cancer Genetic Testing and Treatment Debuts During Breast Cancer Awareness Month

NCCN Guidelines Navigator for Breast Cancer Genetic Testing and Treatment Debuts During Breast Cancer Awareness Month

Today, the National Comprehensive Cancer Network® (NCCN®)—a nonprofit responsible for globally utilized guidelines for cancer care—is sharing new...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

New Products & Services

New Products & Services

Not For Profit

Not For Profit

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.